acrabstracts.org domain details
Domain rank: 659740
Domain speed: Very fast (0.001 seconds at 237.333 MB/s)
Indexed URLs from acrabstracts.org website (10)
The links in column here only counts links from external domains.
found date
links in
url title
url
2022-08-03
Rapid Implementation of a Multidisciplinary COVID-19 Cytokine Storm Syndrome Task Force - ACR Meeting Abstracts
acrabstracts.org/abstract/rapid-implementation-of-a-multidisciplinary-covid-19-cytokine-storm-syndrome-task-force/
2021-06-28
Pooled Safety Results from Two Phase-3 Trials of Guselkumab in Patients with Psoriatic Arthritis Through 1 Year - ACR Meeting Ab
acrabstracts.org/abstract/pooled-safety-results-from-two-phase-3-trials-of-guselkumab-in-patients-with-psoriatic-arthritis-throu ...
2021-06-28
Guselkumab Efficacy in Adult Patients with Active Psoriatic Arthritis by Baseline Demographic and Disease Characteristics: Poole
acrabstracts.org/abstract/guselkumab-efficacy-in-adult-patients-with-active-psoriatic-arthritis-by-baseline-demographic-and-dise ...
2022-08-25
Impact of COVID19 on Missed/Cancelled Rheumatology Office Visits and Parenteral Immunosuppressive Medications - ACR Meeting Abst
acrabstracts.org/abstract/impact-of-covid19-on-missed-cancelled-rheumatology-office-visits-and-parenteral-immunosuppressive-medi ...
2023-01-06
2016 ACR/ARHP Annual Meeting Archives - ACR Meeting Abstracts
2022-08-27
Secukinumab in Giant Cell Arteritis: A Randomized, Parallel-group, Double-blind, Placebo-controlled, Multicenter Phase 2 Trial -
acrabstracts.org/abstract/secukinumab-in-giant-cell-arteritis-a-randomized-parallel-group-double-blind-placebo-controlled-multic ...
2021-06-28
Guselkumab Efficacy and Safety in TNF-Inhibitor-Experienced and TNF-Inhibitor-Naïve Patients with Active PsA: 1-Year Results of
acrabstracts.org/abstract/guselkumab-efficacy-and-safety-in-tnf-inhibitor-experienced-and-tnf-inhibitor-naive-patients-with-acti ...
2022-12-20
Prevalence of Systemic Autoimmune Diseases in Polycystic Ovary Syndrome - ACR Meeting Abstracts
2021-06-28
Efficacy and Safety of Guselkumab, a Monoclonal Antibody Specific to the p19-Subunit of Interleukin-23, Through Week 52 of a Pha
acrabstracts.org/abstract/efficacy-and-safety-of-guselkumab-a-monoclonal-antibody-specific-to-the-p19-subunit-of-interleukin-23- ...
2022-07-07
ACR Convergence 2021 Archives - ACR Meeting Abstracts